Ginkgo Bioworks Inc.
(DNA)
undefined
undefined%
At close: undefined
11.68
1.04%
Pre-market Jan 07, 2025, 06:19 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY01 |
| Net Income | -892.87M | -2.11B | -1.84B | -126.72M | -119.86M | -2.11B |
| Depreciation & Amortization | 71.55M | 44.42M | 29.08M | 13.86M | 10.76M | 44.42M |
| Stock-Based Compensation | 229.88M | 1.93B | 1.61B | 476.00K | 771.00K | 1.93B |
| Other Working Capital | -19.05M | -81.35M | 55.43M | -16.57M | 13.98M | -55.02M |
| Other Non-Cash Items | 266.89M | -69.28M | -20.95M | -1.06M | -1.64M | -55.02M |
| Deferred Income Tax | -801.00K | -14.61M | 30.21M | 4.13M | 54.73M | -14.61M |
| Change in Working Capital | 29.84M | -37.01M | -61.54M | -26.52M | 10.58M | 55.02M |
| Operating Cash Flow | -295.50M | -252.20M | -253.82M | -135.83M | -44.66M | -145.92M |
| Capital Expenditures | -40.80M | -52.27M | -56.52M | -57.82M | -22.22M | n/a |
| Acquisitions | -38.55M | 26.65M | -12.04M | n/a | n/a | n/a |
| Purchase of Investments | n/a | -3.69M | -5.00M | n/a | -50.13M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1.34M | -38.08M | 304.00K | -9.30M | -2.25M | n/a |
| Investing Cash Flow | -80.69M | -67.39M | -73.26M | -67.12M | -74.60M | n/a |
| Debt Repayment | -1.29M | -1.24M | -1.12M | -748.00K | 198.60M | n/a |
| Common Stock Repurchased | -23.00K | n/a | -25.00M | n/a | -408.00K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.90M | -3.96M | 1.56B | 91.07M | 212.19M | n/a |
| Financial Cash Flow | -3.22M | 95.34M | 1.53B | 90.32M | 410.38M | n/a |
| Net Cash Flow | -380.00M | -223.35M | 1.21B | -112.63M | 291.12M | -145.92M |
| Free Cash Flow | -336.30M | -304.47M | -310.34M | -193.65M | -66.88M | -145.92M |